synthetic lysine vasopressin nasal spray in the treatmentof diabetes insipidus.thirteen patients with diabetes insipiduswere satisfactorily and convenientlytreated with synthetic lysine vasopressinnasal spray, the material being administered3 to 5 times per day in a total dailydosage ranging from 35 to 125 u.  atransient decrease in effectiveness was notedduring periods of upper respiratoryinfection or allergic rhinitis.  the only adverseeffects of the nasal spray consistedof minor nasal irritation in 3 patients andincreased frequency of bowel movementsin one child after he increased the dose inan effort to concentrate and restricturine volume.  in hydrated normal subjects,lysine vasopressin administered s.c.is 7.4 times as effective as the nasal spray preparation.